drugset / Trial / NCT01919892

Longitudinal Study on the Neuroprotective and Neurotrophic Effects of Lithium

NCT01919892

Phase 4 Completed 30 enrolled University of Sao Paulo
NaSingle-groupOpen-labelTreatment

Summary

Thirty subjects with a DSM-IV (Diagnostic and Statistical Manual, fourth version)diagnosis of BPD during a depressive or hypomanic episode will be divided in two groups according to age and time of illness. All patients will receive lithium (flexible therapeutic dose) for 6 weeks and improvement will be evaluated weekly using depression and mania rating scales; this study also objectives to identify state/trait markers and predictors of response.

Timeline

Start
2010-09
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Lithium Unknown 450 mg
Subject Lithium Unknown 900 mg

Indications